Skip to main content

Table 2 Concentrations (GE/mL) of plasma ccf nDNA and ccf mtDNA in the 3 study-groups; expressed as median.

From: Levels of plasma circulating cell free nuclear and mitochondrial DNA as potential biomarkers for breast tumors

Group

Total no. of patients

Age

(mean ± S.D.)

Median Ccf nDNA(GE/mL)

Median Ccf mtDNA (GE/mL)

Malignant disease group

52

64 ± 15

4678

205013

Benign disease group

26

41 ± 16

1359

73977

Control group

70

53 ± 14.6

1298

522115